Sudden infant death syndrome: Postulated role of impaired vasoactive neuropeptide-related inflammatory modulation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Pediatric Infectious Diseases

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/JPI-2010-0223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sudden infant death syndrome (SIDS) in African Americans: polymorphisms in the gene encoding the stress peptide pituitary adenylate cyclase‐activating polypeptide (PACAP)

  2009cited by this paper
• The brainstem and serotonin in the sudden infant death syndrome.

  2009cited by this paper
• Purinergic signalling in the nervous system: an overview.

  2009cited by this paper
• Infection and sudden unexpected death in infancy: a systematic retrospective case review.

  2008cited by this paper
• Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjögren's syndrome.

  2008cited by this paper
• Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents.

  2008cited by this paper
• Pituitary adenylate cyclase-activating polypeptide is vital for neonatal survival and the neuronal control of breathing

  2008cited by this paper
• Evidence for infection, inflammation and shock in sudden infant death: parallels between a neonatal rat model of sudden death and infants who died of sudden infant death syndrome

  2008cited by this paper
• Sterile site infection at autopsy in sudden unexpected deaths in infancy

  2008cited by this paper
• An infectious aetiology of sudden infant death syndrome

  2008cited by this paper
• The induced prostaglandin E2 pathway is a key regulator of the respiratory response to infection and hypoxia in neonates

  2007cited by this paper
• Prevalence of Long-QT Syndrome Gene Variants in Sudden Infant Death Syndrome

  2007cited by this paper
• Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.

  2007cited by this paper
• Nicotinic receptor activation occludes purinergic control of central cardiorespiratory network responses to hypoxia/hypercapnia.

  2007cited by this paper
• Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease

  2007cited by this paper
• VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice macrophages.

  2007cited by this paper
• Altered cerebellar development in mice lacking pituitary adenylate cyclase‐activating polypeptide

  2007cited by this paper
• CREB and cAMP response element‐mediated gene expression in the ischemic brain

  2007cited by this paper
• Neuroprotection: a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.

  2007cited by this paper
• Vasoactive Intestinal Peptide Regulates Th17 Function in Autoimmune Inflammation

  2007cited by this paper
• Sudden infant death syndrome

  2007cited by this paper
• Active caspase-3 in the sudden infant death syndrome (SIDS) brainstem

  2007cited by this paper
• Neuronal cell death in the Sudden Infant Death Syndrome brainstem and associations with risk factors.

  2007cited by this paper
• Correction effect of ATP on platelet aggregation and blood coagulation In Vitro and in the presence of circulating thrombin in rats

  2007cited by this paper
• Role of PACAP and VIP in astroglial functions.

  2007cited by this paper
• Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain

  2006cited by this paper
• Sudden infant death syndrome and reported maternal smoking during pregnancy.

  2006cited by this paper
• Serotonergic and glutamatergic neurons at the ventral medullary surface of the human infant: Observations relevant to central chemosensitivity in early human life.

  2006cited by this paper
• Effects of cyclic AMP on the function of the cardiac gap junction during hypoxia.

  2006cited by this paper
• Regulation of platelet functions by P2 receptors.

  2006cited by this paper
• Association of sudden infant death syndrome with VEGF and IL-6 gene polymorphisms.

  2006cited by this paper
• Vasoactive Intestinal Peptide Generates CD4+CD25+ Regulatory T Cells in vivo

  2006influential reference
• Regulation of the T cell response

  2006cited by this paper
• The Transport Systems of the Blood–Brain Barrier

  2005cited by this paper
• Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitors

  2005cited by this paper
• [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].

  2005cited by this paper
• The Blood-Brain Barrier and Its Microenvironment : Basic Physiology to Neurological Disease

  2005cited by this paper
• Neuronal Influence on the Local Control of Microcirculation

  2005cited by this paper
• Blood–Brain Barrier Genomics and Proteomics

  2005cited by this paper
• Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.

  2005cited by this paper
• Immune Functions of Brain Endothelial Cells

  2005cited by this paper
• Cytokine responses and sudden infant death syndrome: genetic, developmental, and environmental risk factors

  2005cited by this paper
• Glial and neuronal alterations in the nucleus tractus solitarii of sudden infant death syndrome victims

  2004cited by this paper
• Sudden neonatal death in PACAP‐deficient mice is associated with reduced respiratory chemoresponse and susceptibility to apnoea

  2004cited by this paper
• Early physiological development of infants with intrauterine growth retardation

  2004cited by this paper
• The Significance of Vasoactive Intestinal Peptide in Immunomodulation

  2004cited by this paper
• Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach.

  2004cited by this paper
• Interleukin-10 and sudden infant death syndrome.

  2004cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide attenuate the cigarette smoke extract-induced apoptotic death of rat alveolar L2 cells.

  2004cited by this paper
• Interleukin 1-beta responses to bacterial toxins and sudden infant death syndrome.

  2004cited by this paper
• Sudden infant death syndrome, infection and inflammatory responses.

  2004cited by this paper
• Interleukin 1-β responses to bacterial toxins and sudden infant death syndrome

  2004cited by this paper
• Clinicopathological correlation between brainstem gliosis using GFAP as a marker and sleep apnea in the sudden infant death syndrome.

  2003cited by this paper
• Impaired long-term potentiation in vivo in the dentate gyrus of pituitary adenylate cyclase-activating polypeptide (PACAP) or PACAP type 1 receptor-mutant mice

  2003cited by this paper
• Vasoactive Intestinal Polypeptide and Pituitary Adenylate Cyclase-Activating Polypeptide Activate Hyperpolarization-Activated Cationic Current and Depolarize Thalamocortical Neurons In Vitro

  2003cited by this paper
• PACAP in Immunity and Inflammation

  2003cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide inhibit the production of inflammatory mediators by activated microglia

  2003cited by this paper
• Delayed neuronal maturation of the medullary arcuate nucleus in sudden infant death syndrome

  2003cited by this paper
• Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated cyclic AMP synthesis in rat cerebral cortical slices: interaction with noradrenaline, adrenaline, and forskolin.

  2002cited by this paper
• Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death

  2002cited by this paper
• Depression of hypoxic arousal response in adolescent mice following antenatal vasoactive intestinal polypeptide blockade

  2002cited by this paper
• Arousal deficiency theory in sudden infant death syndrome with reference to neuronal plasticity.

  2002cited by this paper
• Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated cyclic AMP synthesis in rat cerebral cortical slices

  2002cited by this paper
• Pituitary adenylate cyclase-activating polypeptide (PACAP) prevents hippocampal neurons from apoptosis by inhibiting JNK/SAPK and p38 signal transduction pathways

  2002cited by this paper
• Neuropathology of sudden infant death (syndrome): literature review and evidence of a probable apoptotic degenerative cause

  2002cited by this paper
• De Novo Mutation in the SCN5A Gene Associated With Early Onset of Sudden Infant Death

  2001cited by this paper
• Serotonin Transporter Gene Variation Is a Risk Factor for Sudden Infant Death Syndrome in the Japanese Population

  2001cited by this paper
• Molecular diagnosis in a child with sudden infant death syndrome.

  2001cited by this paper
• A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics.

  2001cited by this paper
• Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis

  2001cited by this paper
• The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.

  2001cited by this paper
• SIDS: more facts and controversies

  2001cited by this paper
• Mechanism for Pituitary Adenylate Cyclase‐Activating Polypeptide‐Induced Atrial Fibrillation

  2001cited by this paper
• Immune surveillance of mouse brain perivascular spaces by blood‐borne macrophages

  2001cited by this paper
• Neuroendocrine-Immune Interactions

  2001cited by this paper
• Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.

  2000cited by this paper
• Association of IL-10 genotype with sudden infant death syndrome.

  2000cited by this paper
• Nicotinic acetylcholine receptor agonists promote survival and reduce apoptosis of chick ciliary ganglion neurons.

  2000cited by this paper
• Sudden infant death syndrome: a toxic response.

  2000cited by this paper
• The complement component C4 in sudden infant death

  1999cited by this paper
• Immune and inflammatory responses in sudden infant death syndrome.

  1999cited by this paper
• Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase.

  1999cited by this paper
• The effect of prone posture on nasal temperature in children in relation to induction of staphylococcal toxins implicated in sudden infant death syndrome.

  1999cited by this paper
• The amount of brainstem gliosis in sudden infant death syndrome (SIDS) victims correlates with maternal cigarette smoking during pregnancy

  1999cited by this paper
• Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors.

  1999cited by this paper
• The nasopharyngeal bacterial flora in infancy: effects of age, gender, season, viral upper respiratory tract infection and sleeping position.

  1999cited by this paper
• Role of central nervous system microvascular pericytes in activation of antigen‐primed splenic T‐lymphocytes

  1999cited by this paper
• Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life.

  1998cited by this paper
• Detection of respiratory syncytial virus nucleic acid in archival postmortem tissue from infants.

  1997cited by this paper
• Combined effects of sleeping position and prenatal risk factors in sudden infant death syndrome: the Nordic Epidemiological SIDS Study.

  1997cited by this paper
• The A985 to G mutation of the medium‐chain acyl‐CoA dehydrogenase gene and sudden infant death syndrome in Normandy

  1996cited by this paper
• VIP-like immunoreactivity within neurons and perivascular neuronal processes of the human cerebral cortex.

  1996cited by this paper
• Flow cytometry cross-match.

  1996cited by this paper
• Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent.

  1996cited by this paper
• Brain stem gliosis in the victims of sudden infant death syndrome (SIDS): a sign of retarded maturation?

  1995cited by this paper
• S cases have increased levels of interleukin‐6 in cerebrospinal fluid

  1995cited by this paper
• Brain stem gliosis in the victims of sudden infant death syndrome (SIDS) : a sign of retarded maturation ?

  1995cited by this paper
• Effects of pituitary adenylate cyclase-activating polypeptide on cardiovascular and respiratory responses in anaesthetised dogs.

  1995cited by this paper
• The role of infectious agents in sudden infant death syndrome.

  1994cited by this paper
• T-cell infiltration and expression of MHC class II antigen by macrophages and microglia in a heterogeneous group in leukoencephalopathy.

  1993cited by this paper

• Respiratory pathogens in cases of sudden unexpected death in infants (SUDI) at Tygerberg Forensic Pathology Service Mortuary

  2014cites this paper